| |
 |
| |
Theme |
| |
Safe,
effective and appropriate medicines remain a cornerstone of healthcare
provision. The benefits to patients of controlling disease and the
pathologies of old age cannot be underestimated. Modern medicines are
potent compounds that can bring life-saving treatments and relief of
symptoms to millions of people. But the challenge of bringing safe and
effective medicines to the market brings with it considerable risk for
all stakeholders. |
| |
|
|
 |
The theme of BPC 2007,
The medicines maze: balancing risks and benefits, addresses the
many facets of this conundrum. Reducing risk and maximising benefit
must be addressed by scientists and the pharmaceutical industry, by
the regulators and governments and by the patient and healthcare
professionals. |
|
| |
 |
For scientists and the
pharmaceutical industry, the risks involved in the introduction of new
chemical entities are immense. Innovators endeavour to make medicines
which are safe and effective. This involves engaging in costly
clinical trials that might reveal unexpected pharmacological actions.
These findings may affect reputations. Once
a medicine has been brought to market, the pharmaceutical industry and
regulators must work together to combat counterfeiting. |
|
|
 |
The regulators need to
show consistency in their approach to the risks and benefits of
licensing and in issuing guidance on new medicines and other
treatments, against the backdrop of increasing patient demands.
Similarly, health service organisations face the challenge of
balancing priorities and weighing up the risks and benefits of
providing various services within finite resources. |
|
|
 |
For the healthcare
professional, the challenges include the increasing awareness of
patient need; the growth of litigation; and the myriad new treatments
and guidance being launched each year. On top of this, they must
balance the usual risks and benefits associated with diagnosis and
treatments. |
|
| |
 |
Patients’ priorities and
needs are, of course, at the heart of all decisions. Patients need a
better way of understanding the risks and benefits of treatments in
order that they can make informed decisions. Today, despite the growth
in information in the media and on the Internet, patients and the
public still need expert support for their health choices. The
increasing popularity of complementary medicines or a reliance on
traditional medicine are also risk factors. The RPSGB and other heath
regulators must tackle the challenge of supporting a safe and workable
framework for medicines development, management and delivery. |
|
| |
 |
Balancing risks and
benefits is therefore the challenge that patients, pharmacists and
scientists have to face to find the most appropriate outcome. BPC 2007
will tackle all of these issues in the usual mix of leading edge
scientific symposia, sessions on the challenges for policy and
practice and lively discussions and debate. |
|
| |
|
|
| |
The conference exhibition |
| |
Continuing the theme of linking science
and practice, a comprehensive exhibition will run alongside the
conference from 10-12 September in the purpose-built exhibition halls
of Manchester Central (formerly known as Manchester International
Convention Centre). The exhibition will feature stands and
demonstrations of interest to scientists and practitioners alike, to
provide a wealth of information and new ideas. The conference
exhibition will provide a one stop
shop for all those wanting to learn about the latest developments in
their field and to network with colleagues from home and abroad.
Poster viewing, networking areas and catering will all be available in
the exhibition area. If you are
interested in exhibiting your organisation's developments at BPC 2007
then email
channey@health-links.co.uk for
further information. A wide range of sponsorship opportunities are
also available. |
| |
|
| |
 |
| |
Repeating the success of BPC 2006, the
exhibition area will also play host to a BPC-PJ Careers Forum. Here,
organisations will be able to outline career opportunities within
their organisation and arrange preliminary interviews with potential
employees from across the profession. |
| |
|
| |
Manchester Central |
| |
Based in the centre of
Manchester, Manchester Central (previously known as Manchester
International Convention Centre) is one of the leading conference
venues in Europe. Manchester is a lively city and is ideally placed
with easy transport links for road, rail and air. The city has
accommodation to suit all price ranges and some of the best shopping
and restaurants in the country. |
| |
|
| |
Accommodation |
| |
|
| |
Continuing
Professional Development |
| |
BPC 2007 will be
accredited by the College of Pharmacy Practice and attendance at the
professional sessions may contribute towards College members meeting
the College requirements for continuing education. |
| |
Attending BPC 2007 is an
ideal opportunity to learn and to identify things that you have
learned and may wish to enter into your Society CPD record. Further
details of how you can do this will be available at the BPC. |
| |
|
| |
Health
Links |
| |
- In 2007, the conference
administration will be run on behalf of the RPSGB by:
- Health
Links,
- Windsor House, 11A High Street,
- Kings Heath,
Birmingham B14 7BB
Tel: 0121 248 3399
Fax: 0121 248 3390
email Angela Lyons for further information:
alyons@health-links.co.uk
|
| |
|
| |
top
of this page ↑ |
| |
|
|
home
- theme
-
highlights
- programme -
social events -
call for papers
-
booking -
press releases -
awards |